These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24011266)

  • 1. Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection.
    Miyake M; Ross S; Lawton A; Chang M; Dai Y; Mengual L; Alcaraz A; Giacoia EG; Goodison S; Rosser CJ
    BMC Urol; 2013 Sep; 13():42. PubMed ID: 24011266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
    Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S
    PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-analyte assay for the non-invasive detection of bladder cancer.
    Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
    PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.
    Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ
    J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
    Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
    J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
    Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
    BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
    Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
    Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
    Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.
    Yang N; Feng S; Shedden K; Xie X; Liu Y; Rosser CJ; Lubman DM; Goodison S
    Clin Cancer Res; 2011 May; 17(10):3349-59. PubMed ID: 21459797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.
    Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W
    Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplex immunoassay for the non-invasive detection of bladder cancer.
    Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
    J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary BTA: indicator of bladder cancer or of hematuria.
    Miyake M; Goodison S; Rizwani W; Ross S; Bart Grossman H; Rosser CJ
    World J Urol; 2012 Dec; 30(6):869-73. PubMed ID: 22932760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
    Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
    Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-8 as a urinary biomarker for the detection of bladder cancer.
    Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ
    BMC Urol; 2012 May; 12():12. PubMed ID: 22559832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
    Arnold SA; Loomans HA; Ketova T; Andl CD; Clark PE; Zijlstra A
    Clin Exp Metastasis; 2016 Jan; 33(1):29-44. PubMed ID: 26456754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
    Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex protein signature for the detection of bladder cancer in voided urine samples.
    Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S
    J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
    Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T
    J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
    Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
    Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.